Top Page
Science
(LSE:SAG)
Science (SAG) vs. iShares MSCI United Kingdom ETF (EWC)
Science Business Overview & Revenue Model
Science Financial Statement Overview
| Breakdown | ||||
| Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|
| Income Statement | Total Revenue | |||
| 110.67M | 113.34M | 86.30M | 81.22M | 73.66M | Gross Profit |
| 45.18M | 46.25M | 38.35M | 35.36M | 29.80M | EBIT |
| 14.88M | 8.14M | 11.70M | 11.58M | 7.13M | EBITDA |
| 21.13M | 15.15M | 16.64M | 16.00M | 11.62M | Net Income Common Stockholders |
| 12.02M | 5.52M | 10.55M | 9.56M | 7.04M |
| Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
| 41.45M | 32.83M | 46.51M | 37.19M | 29.07M | Total Assets |
| 141.09M | 132.45M | 127.28M | 115.94M | 92.05M | Total Debt |
| 15.49M | 16.90M | 16.02M | 16.88M | 18.79M | Net Debt |
| -25.96M | -15.93M | -30.49M | -20.31M | -10.28M | Total Liabilities |
| 57.09M | 54.46M | 49.08M | 49.64M | 50.66M | Stockholders Equity |
| 84.00M | 77.99M | 78.20M | 66.29M | 41.39M |
| Cash Flow | Free Cash Flow | |||
| 18.48M | 7.83M | 15.18M | 9.15M | 17.54M | Operating Cash Flow |
| 18.48M | 7.91M | 15.27M | 14.01M | 17.69M | Investing Cash Flow |
| 723.00K | -12.78M | -34.00K | -19.08M | -134.00K | Financing Cash Flow |
| -10.72M | -8.49M | -6.46M | 13.08M | -3.53M |
Science Technical Analysis
Science Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | £195.06M | 22.69 | 45.84% | 4.03% | 12.22% | 7.48% | |
73 Outperform | £302.93M | 18.62 | 13.02% | 1.94% | 29.64% | -7.27% | |
71 Outperform | £228.16M | 19.35 | 14.84% | 1.56% | -2.36% | 117.49% | |
68 Neutral | £171.57M | 29.20 | 7.13% | 0.05% | 4.95% | -53.49% | |
66 Neutral | $4.44B | 12.08 | 5.34% | 5.82% | 4.17% | -11.81% | |
56 Neutral | £133.17M | 29.69 | -3.96% | 12.88% | -16.16% | -145.46% | |
53 Neutral | £268.76M | 205.36 | -5.28% | 0.78% | -8.12% | -794.85% |
Science Corporate Events
Science Group PLC, a UK-based company, has announced a significant change in its voting rights structure. Canaccord Genuity Group Inc., based in Vancouver, Canada, has reduced its voting rights in Science Group PLC from 9.8683% to 4.9888% as of June 18, 2025. This adjustment in holdings indicates a strategic shift that may influence the company’s governance and decision-making processes, potentially impacting stakeholders and market perceptions.
The most recent analyst rating on (GB:SAG) stock is a Buy with a £620.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.
Science Group PLC has announced the sale of its entire holding in Ricardo plc, resulting in a net return of approximately £23.7 million after brokerage fees and related costs. The company plans to use the proceeds to increase its share buy-back authorization, managed by Panmure Liberum Limited, and anticipates releasing its interim results for the period ending 30 June 2025 by the end of July.
The most recent analyst rating on (GB:SAG) stock is a Buy with a £620.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.
Science Group PLC has announced the repurchase of 10,000 of its ordinary shares at a price of 511.0 pence per share, which represents 0.02% of the voting rights of the total ordinary shares prior to the purchase. This transaction is part of the company’s ongoing buyback program, and the shares will be held in treasury, potentially impacting shareholder calculations under the FCA’s Disclosure Guidance and Transparency Rules.
The most recent analyst rating on (GB:SAG) stock is a Buy with a £620.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.
Science Group PLC has announced the sale of a significant portion of its shares in Ricardo plc to WSP Group Limited, resulting in a substantial profit. The transaction will generate approximately £53.5 million in cash proceeds, which Science Group plans to use for future strategic investments. The sale supports WSP’s offer for Ricardo, providing a 102% premium over Ricardo’s previous share price, benefiting all shareholders involved.
The most recent analyst rating on (GB:SAG) stock is a Buy with a £620.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.
Science Group PLC announced the repurchase of 5,000 of its own shares at a price of 463.0 pence per share, representing 0.01% of the voting rights. These shares will be held in treasury, and the total number of ordinary shares in issue, excluding treasury shares, is now 44,529,355. This move is part of the company’s ongoing buyback program, which could impact shareholder calculations under the FCA’s Disclosure Guidance and Transparency Rules.
The most recent analyst rating on (GB:SAG) stock is a Buy with a £620.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.
Science Group PLC has repurchased 5,000 of its ordinary shares at an average price of 463.5 pence per share, representing 0.01% of the voting rights. This transaction, conducted through Panmure Liberum Limited, is part of the company’s share buyback program and impacts the total number of shares in issue, which now stands at 44,534,355, excluding treasury shares.
The most recent analyst rating on (GB:SAG) stock is a Buy with a £620.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.
Science Group PLC announced the repurchase of 5,000 of its ordinary shares at a price of 463.5 pence each, representing 0.01% of its voting rights. This transaction, executed through Panmure Liberum Limited, is part of the company’s share buyback program, impacting the total number of shares in issue and potentially affecting shareholder calculations under regulatory guidelines.
The most recent analyst rating on (GB:SAG) stock is a Buy with a £620.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.
Science Group PLC has announced that ISS, an independent proxy agency, has recommended voting in favor of removing Ricardo plc’s Chairman, Mr. Mark Clare, due to the company’s ongoing poor performance and ineffective strategy implementation. Science Group supports this recommendation and encourages Ricardo shareholders to vote for the resolution at the upcoming General Meeting, highlighting concerns about Ricardo’s performance and its relative underperformance compared to peers.
The most recent analyst rating on (GB:SAG) stock is a Buy with a £620.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.
Science Group PLC has announced its total issued share capital, excluding treasury shares, consists of 44,544,355 shares of 1 penny each, with 1,641,519 shares held in treasury. This figure is crucial for shareholders as it serves as the denominator for calculating their interests or changes in interests in the company, in compliance with the FCA’s Disclosure and Transparency Rules.
The most recent analyst rating on (GB:SAG) stock is a Buy with a £620.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.
Science Group PLC has increased its investment in Ricardo plc to 21.8% of the voting rights, following concerns over Ricardo’s poor performance and governance issues. The company has called for a general meeting to vote on the removal of Ricardo’s Chairman, aiming to initiate changes that align with shareholder interests and improve Ricardo’s performance.
The most recent analyst rating on (GB:SAG) stock is a Buy with a £620.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.
Science Group PLC has repurchased 4,500 of its ordinary shares at a price of 464.0 pence each, representing 0.01% of the voting rights. This transaction, executed through Panmure Liberum Limited, is part of the company’s share buyback program and will see the shares held in treasury, impacting the total number of shares available for shareholder calculations under regulatory guidelines.
The most recent analyst rating on (GB:SAG) stock is a Buy with a £620.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.
Science Group PLC announced the purchase of 2,500 of its ordinary shares at a price of 477.0 pence per share, representing 0.01% of the voting rights before the purchase. These shares will be held in treasury, affecting the total number of shares in issue, which now stands at 44,548,855. This transaction is part of the company’s ongoing strategy to manage its capital structure and potentially increase shareholder value.
The most recent analyst rating on (GB:SAG) stock is a Buy with a £620.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.
Science Group PLC announced that all resolutions at their Annual General Meeting were passed, including the adoption of financial statements for 2024, reappointment of auditors, and approval of a final dividend of 8.0 pence per share. This successful meeting reflects strong shareholder support and positions the company for continued stability and growth, benefiting stakeholders by reinforcing its market presence and operational strategies.
The most recent analyst rating on (GB:SAG) stock is a Buy with a £620.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.
Science Group PLC reports a strong start to the year with revenue and profitability exceeding expectations despite global volatility. The company has successfully completed an IT system migration across its consultancy division, enhancing operational efficiency and resilience. Additionally, Science Group is actively engaging with Ricardo PLC, where it holds a 20.08% share, to address strategic and governance concerns, leading to the requisition of a general meeting.
The most recent analyst rating on (GB:SAG) stock is a Buy with a £620.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.
Science Group PLC, a company listed on the AIM market, announced the repurchase of 5,000 of its ordinary shares at a price of 476.0 pence per share. This transaction represents a minor portion of the company’s voting rights and will be held in treasury, adjusting the total number of shares in issue. This move is part of the company’s ongoing buyback program, which may impact shareholder calculations under FCA regulations.
The most recent analyst rating on (GB:SAG) stock is a Buy with a £620.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.
Science Group PLC announced the repurchase of 7,500 of its ordinary shares at a price of 458.0 pence per share, representing 0.02% of the voting rights. These shares will be held in treasury, affecting the total number of shares in issue and potentially impacting shareholder calculations under FCA rules.
The most recent analyst rating on (GB:SAG) stock is a Buy with a £620.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.
Science Group PLC has issued 10,000 treasury shares at an average price of 1 pence per share to settle the exercise of share options. This action adjusts the total number of ordinary shares in issue to 44,567,805, excluding treasury shares, and holds implications for shareholder notifications under regulatory guidelines.
Science Group PLC has announced the issuance of share options over 260,000 ordinary shares to 26 employees as part of its annual option grant under the Performance Share Plan. These options will vest after three years, contingent on meeting specific Earnings per Share growth targets from 2025 to 2027, and are exercisable at a nominal value for seven years post-vesting. This move is part of the company’s strategy to incentivize and retain key personnel, potentially enhancing its competitive position in the market.
Science Group PLC announced the repurchase of 5,000 of its ordinary shares at a price of 446.0 pence per share, representing 0.01% of the voting rights. This transaction, executed through Panmure Liberum Limited, is part of the company’s buyback program and will result in the shares being held in treasury. The total number of ordinary shares in issue, excluding treasury shares, now stands at 44,557,805. This move may impact shareholders’ calculations regarding their interest in the company under FCA’s regulations.
Science Group PLC, a major shareholder in Ricardo plc, has raised concerns about Ricardo’s strategic direction and financial performance. Despite being the second-largest shareholder with a 20.08% stake, Science Group criticizes Ricardo’s recent Business & Strategy Update for failing to address key financial challenges and for not providing a clear path to recovery. The update highlighted a significant downgrade in financial forecasts, including a projected loss in operating profit and reduced cash flow, which has led to a call for leadership changes at Ricardo. Science Group is advocating for a strategic review and possible restructuring of Ricardo to restore shareholder value, while also considering potential sale options due to the company’s deteriorating financial position.
Science Group PLC has announced its total issued share capital, excluding treasury shares, which consists of 44,562,805 shares of 1 penny each. The company holds 1,623,069 shares in treasury. This information is crucial for shareholders as it helps them determine their notification requirements under the FCA’s Disclosure and Transparency Rules, impacting their interest calculations in the company.
Science Group PLC has executed a share buyback, purchasing 2,893 of its ordinary shares at an average price of 438.5 pence per share. This transaction represents a minor portion of the company’s total voting rights and is part of a strategic move to manage its share capital. The shares will be held in treasury, adjusting the total number of shares available for shareholder calculations under regulatory guidelines.
Science Group PLC announced the repurchase of 5,000 ordinary shares at a price of 445.0 pence per share, representing 0.01% of the voting rights. The shares will be held in treasury, and the total number of ordinary shares in issue, excluding treasury shares, is now 44,565,698. This buyback may influence shareholder calculations regarding their interest in the company, as per FCA’s Disclosure Guidance and Transparency Rules.
Science Group PLC reported a strong start to 2025 with revenue and profitability slightly exceeding expectations, despite volatile market conditions. The company highlighted its robust balance sheet and strong operating cash flow. In contrast, Science Group criticized Ricardo PLC, where it holds a significant share, for poor financial management and lack of strategic clarity, which has led to a significant decline in shareholder value. Science Group’s engagement has prompted some acknowledgment of issues by Ricardo’s board, but the latter’s performance remains underwhelming compared to its peers.
Science Group PLC has repurchased 7,500 of its ordinary shares at a consistent price of 413.0 pence per share, representing 0.02% of the voting rights. This transaction, executed through Panmure Liberum Limited, is part of the company’s ongoing share buyback program, potentially impacting shareholder calculations under the FCA’s rules.
Science Group PLC announced the repurchase of 9,500 of its ordinary shares at an average price of 415.79 pence per share, as part of its ongoing share buyback program. This transaction represents 0.02% of the voting rights and will see the shares held in treasury, adjusting the total number of shares in issue to 44,578,198. This move may influence shareholder calculations regarding their interests in the company under regulatory guidelines.
Science Group plc, a company listed on the AIM market, announced the repurchase of 5,000 of its ordinary shares at a price of 418.0 pence each. This transaction represents a small fraction of the company’s total voting rights and is part of a buyback program executed through Panmure Liberum Limited. The repurchased shares will be held in treasury, affecting the total number of shares available for shareholder calculations under regulatory guidelines.
Science Group PLC announced the repurchase of 5,000 of its ordinary shares at an average price of 414.5 pence per share, representing 0.01% of the voting rights. This transaction, executed through Panmure Liberum Limited, is part of the company’s share buyback program, with the purchased shares held in treasury. The total number of ordinary shares in issue, excluding treasury shares, is now 44,592,698. This move may impact shareholder calculations regarding their interests in the company under FCA rules.
Science Group PLC announced the repurchase of 5,000 of its ordinary shares at a price of 415.0 pence per share, which will be held in treasury. This transaction represents 0.01% of the voting rights of the total ordinary shares, and the updated number of shares in issue is 44,597,698. This move is part of the company’s buyback program and may impact shareholder calculations under the FCA’s Disclosure Guidance and Transparency Rules.
Science Group PLC has announced that its Annual General Meeting (AGM) will take place on May 21, 2025, at its London office. The company has made its Annual Report and Financial Statements for the year ending December 31, 2024, available on its website, with hard copies sent to shareholders who prefer paper communications. The AGM will feature voting conducted via a poll, and the board encourages shareholders to appoint the Chair as their proxy to ensure their votes are counted.
Science Group PLC announced the repurchase of 10,000 of its ordinary shares at a price of 419.0 pence per share, representing 0.02% of the voting rights. This transaction, executed through Panmure Liberum Limited, is part of the company’s ongoing buyback program and affects the total number of shares available for shareholder calculations under regulatory guidelines.
Science Group PLC has announced a share buyback, purchasing 4,761 of its ordinary shares at an average price of 419.0 pence per share. This transaction represents a minor 0.01% of the voting rights of the total ordinary shares in issue. The shares will be held in treasury, and the total number of ordinary shares in issue, excluding treasury shares, now stands at 44,612,698. This move allows shareholders to use this figure for regulatory calculations under the FCA’s Disclosure Guidance and Transparency Rules, potentially impacting shareholder notifications and interests.
Science Group PLC has announced the repurchase of 10,000 of its ordinary shares at a price of 413.0 pence per share, representing 0.02% of the voting rights. These shares will be held in treasury, adjusting the total number of ordinary shares in issue to 44,617,459. This transaction is part of the company’s ongoing share buyback program, which could impact shareholder calculations under the FCA’s Disclosure Guidance and Transparency Rules.
Science Group PLC announced the repurchase of 2,500 of its ordinary shares at a price of 418.0 pence per share, representing a minor fraction of its total voting rights. This transaction is part of the company’s buyback program, and the repurchased shares will be held in treasury, potentially impacting shareholder calculations under FCA rules.
Science Group PLC has increased its stake in Ricardo plc to over 20%, marking a strategic milestone achieved in a short period. This investment comes amid concerns about Ricardo’s poor operating performance and governance issues, with Science Group advocating for a realignment of Ricardo’s board to better address current market challenges and prioritize shareholder interests.
Science Group PLC announced the repurchase of 5,000 of its ordinary shares at a price of 421.25 pence per share, representing 0.01% of the voting rights. This transaction is part of the company’s ongoing share buyback program, which aims to manage its capital structure effectively. The repurchased shares will be held in treasury, and the total number of ordinary shares in issue, excluding treasury shares, is now 44,629,959. This move may impact shareholders’ calculations regarding their interest in the company under regulatory guidelines.
Science Group plc announced that its Executive Chair, Martyn Ratcliffe, has purchased 10,000 ordinary shares at 410 pence each, increasing his total shareholding to approximately 21.27% of the company’s issued share capital. This transaction signifies Ratcliffe’s continued confidence in the company’s future prospects and may positively influence stakeholder perception of the company’s stability and growth potential.
Science Group PLC has announced the repurchase of 5,000 of its ordinary shares at a price of 428.5 pence per share, representing 0.01% of the voting rights. This transaction, executed through Panmure Liberum Limited, is part of the company’s strategy to manage its share capital effectively, with the purchased shares being held in treasury. The total number of ordinary shares in issue, excluding treasury shares, now stands at 44,634,959. This move could impact shareholder calculations under the FCA’s Disclosure Guidance and Transparency Rules.
Science Group PLC announced the purchase of 1,246 of its own ordinary shares at a consistent price of 431.0 pence per share. This transaction represents a minor portion of the company’s voting rights and is part of a buyback program, with the shares being held in treasury. The move is likely aimed at optimizing the company’s capital structure and enhancing shareholder value.
Science Group PLC has increased its shareholding in Ricardo plc to 17.32%, becoming the second largest shareholder in the company. This strategic move could potentially strengthen Science Group’s influence in the science and technology sector, impacting its market positioning and stakeholder interests.
Science Group PLC has announced the repurchase of 3,500 of its ordinary shares at a consistent price of 436.0 pence per share. This transaction represents a small fraction of the company’s total voting rights and the repurchased shares will be held in treasury. Following this buyback, the total number of ordinary shares in issue, excluding treasury shares, stands at 44,641,205. This figure will be used by shareholders for regulatory calculations under the FCA’s Disclosure Guidance and Transparency Rules.
Science Group PLC has expressed concerns over Ricardo PLC’s management and financial performance, highlighting issues such as poor cash conversion, inadequate financial processes, and excessive executive remuneration. Despite similar market conditions, Science Group has outperformed Ricardo, raising questions about Ricardo’s governance and strategic decisions. Science Group holds a significant shareholding in Ricardo and has called for improvements in governance and transparency to benefit all shareholders.
Science Group PLC announced the repurchase of 3,000 of its ordinary shares at a consistent price of 429.0 pence per share, executed through Panmure Liberum Limited. This transaction represents a minor portion of the company’s total voting rights and will be held in treasury, potentially impacting shareholder calculations under FCA rules.
Science Group plc, a company listed on the AIM market, announced the issuance of 10,000 treasury shares at an average price of 1 pence per share to settle the exercise of share options. Following this transaction, the total number of ordinary shares in issue, excluding treasury shares, is 44,647,705. This figure is relevant for shareholders to determine any necessary notifications under the FCA’s Disclosure Guidance and Transparency Rules.
Science Group PLC announced the repurchase of 10,000 of its ordinary shares at a price of 437.0 pence per share, representing 0.02% of the voting rights before the purchase. This transaction is part of the company’s buyback program and will result in the shares being held in treasury, impacting the total number of shares available for shareholder calculations under FCA rules.
Science Group PLC announced that its Executive Chair, Martyn Ratcliffe, has purchased 10,000 ordinary shares at 436 pence each, increasing his total holdings to approximately 21.24% of the company’s issued share capital. This transaction highlights Ratcliffe’s confidence in the company’s future prospects and may positively influence stakeholder perception, reinforcing the company’s stability and potential for growth.
Science Group PLC announced that its Executive Chair, Martyn Ratcliffe, has purchased 10,000 ordinary shares in the company, increasing his total shareholding to approximately 21.22% of the issued share capital. This move signifies a strong vote of confidence in the company’s future prospects, potentially impacting investor perception and market positioning.
Science Group plc announced that its Group Managing Director, Daniel Edwards, has purchased 6,667 ordinary shares at 425 pence each, increasing his total holding to approximately 0.22% of the company’s issued share capital. This transaction reflects a continued confidence in the company’s prospects by its leadership, although it does not alter the shareholding positions of other directors.
Science Group plc reported a record adjusted operating profit of £21.5 million for the year ended 31 December 2024, despite a slight decline in revenue to £110.7 million. The company maintained a strong balance sheet with significant cash resources, enabling an investment in Ricardo plc, making Science Group the second largest shareholder. The Group’s Consultancy Division saw a decrease in revenue due to market conditions and strategic refocusing, while its Systems Businesses reported increased revenue and profit. The company plans to continue its share buy-back program and maintain its dividend, reflecting its capital allocation strategy.